Secondary malignancies in non‐Hodgkin lymphoma survivors: 40 years of follow‐up assessed by treatment modality

por Parsons, Matthew W., Rock, Calvin, Chipman, Jonathan J., Shah, Harsh R., Hu, Boyu, Stephens, Deborah M., Tao, Randa, Tward, Jonathan D., Gaffney, David K.
Publicado 2022

Second Primary Malignancies in Diffuse Large B-cell Lymphoma Survivors with 40 Years of Follow Up: Influence of Chemotherapy and Radiation Therapy

por Rock, Calvin B., Chipman, Jonathan J., Parsons, Matthew W., Weil, Chris R., Hutten, Ryan J., Tao, Randa, Tward, Jonathan D., Shah, Harsh R., Hu, Boyu, Stephens, Deborah M., Gaffney, David K.
Publicado 2022

A roadmap to using randomization in clinical trials

por Berger, Vance W., Bour, Louis Joseph, Carter, Kerstine, Chipman, Jonathan J., Everett, Colin C., Heussen, Nicole, Hewitt, Catherine, Hilgers, Ralf-Dieter, Luo, Yuqun Abigail, Renteria, Jone, Ryeznik, Yevgen, Sverdlov, Oleksandr, Uschner, Diane
Publicado 2021